Introduction {#s1}
============

Asthma is one of the leading prevalent paediatric chronic diseases in the world \[[@C1]\]. Evidence shows that both genetic and environmental factors are responsible for the development of asthma \[[@C2]\]. A number of epidemiological studies have reported associations between ambient air pollution and childhood asthma incidence \[[@C3], [@C4]\] as well as lung function deficits \[[@C5]--[@C8]\], with some studies suggesting that this relationship may begin *in utero* \[[@C5], [@C9]--[@C16]\]. However, most studies have been restricted to urban populations living in the vicinity of air pollution monitoring stations and therefore, further evidence is required when comparing urban and rural populations in childhood asthma risk. In addition, further evidence is needed in order to disentangle the importance of different prenatal and postnatal periods of exposure for childhood asthma incidence.

One of the strongest risk factors for childhood asthma development is the presence of a maternal history of asthma \[[@C17]--[@C19]\]. Asthma is the most common chronic disease to affect pregnant women \[[@C20]\], but no studies to date have evaluated whether the effect of prenatal exposure to outdoor air pollution on childhood asthma incidence is enhanced among children of mothers with a history of asthma, or whether their joint effects increase risk of childhood asthma. Sex differences in the relationship between exposure to outdoor air pollution and risk of childhood asthma development have been observed, but inconsistent findings have been reported \[[@C9], [@C11], [@C12]\]. For instance, it is hypothesised that male infants could be more susceptible to the harmful effects of air pollution due to their specific pulmonary phenotype compared to female infants \[[@C7]\]. One previous study showed that infants born preterm and of low birthweight are at increased risk of developing asthma when exposed to increased levels of outdoor air pollution \[[@C11]\], but this requires further investigation. Other potential modifying factors for which further evidence is needed include maternal smoking during pregnancy and maternal atopy \[[@C21]\].

In this study, we made use of a large population-based sample encompassing both urban and rural areas to evaluate the associations between exposures during pregnancy and early postnatal life to nitrogen dioxide (NO~2~) as a marker of traffic-related air pollution and particulate matter with a 50% cut-off aerodynamic diameter ≤2.5 μm (PM~2.5~) as a marker of the complex mixture of outdoor air pollution, with childhood asthma incidence. We further examined whether these associations were modified by maternal history of asthma, maternal atopy, maternal smoking during pregnancy, infant sex, gestational age, birthweight and maternal place of residence (urban/rural areas).

Methods {#s2}
=======

Study population and design {#s2a}
---------------------------

We identified a retrospective cohort of pregnant women who gave birth to live-born singleton infants in the province of Ontario, Canada. Mother--infant-pair data were obtained from a province-wide birth registry for the time period between April 1, 2006 and March 31, 2012 \[[@C22]\]. Each mother\'s residential location(s) during pregnancy was obtained based on residential postal code(s) reported from health administrative databases. Gestational age was determined by first trimester ultrasound dating and the mother\'s last menstrual period (see the [online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials) for more details on study population).

Ascertainment of childhood asthma {#s2b}
---------------------------------

We identified incident childhood asthma cases (International Classification of Diseases, 10th revision (ICD-10): J45) for the time period April 1, 2006 to March 31, 2013 using the Ontario Asthma Surveillance Information System, which is a population-based system that identifies and tracks individuals living with asthma in Ontario, Canada \[[@C23]\]. A previously validated case definition of asthma was used to identify individuals with asthma ([online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials)). We examined incident childhood asthma diagnosed between birth and \<6 years of age, consistent with prior literature \[[@C9], [@C11]\]. The data linkage process across databases and linkage with exposure estimates is depicted in [online supplementary figure S1](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials). For instance, 222 864 participants could be assigned exposure estimates to both PM~2.5~ and NO~2~ (exposure assessment described below). These datasets were linked using unique encoded identifiers and analysed at the Institute for Clinical Evaluative Sciences.

Exposure assessment {#s2c}
-------------------

Air pollution exposure estimates were assigned to the geographical coordinates representing the centroid of each subject\'s residential 6-digit postal code, as previously described \[[@C24], [@C25]\]. In brief, we assigned exposure to PM~2.5~ during each trimester of pregnancy and during the first year of life, and for the cumulative exposure after birth, based on monthly satellite surfaces at a 1×1 km resolution \[[@C26], [@C27]\]. Estimates were obtained for trimester-specific periods of exposure and were averaged to obtain estimates for the entire pregnancy.

A national land use regression (LUR) model was used to assign prenatal and postnatal exposure estimates to ambient NO~2~ to residential postal codes \[[@C25], [@C28], [@C29]\]. We applied a temporal adjustment to the LUR NO~2~ model, which allowed us to more precisely obtain estimates of exposure to NO~2~ during each trimester of pregnancy, during the first year of life and for the cumulative exposure after birth. We captured residential mobility during pregnancy by calculating the time spent at each postal code and assigned pollutant exposure accordingly. Additional details regarding exposure assessment methods to ambient air pollutants can be found in the [online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials).

Covariates {#s2d}
----------

The following variables were available from health administrative databases and were investigated as potential confounders and/or effect modifiers \[[@C9], [@C11]\]: maternal age at delivery (\<20 years, 20--34 years, ≥35 years or missing data), infant sex, parity (0, 1 or ≥2), maternal intention to breastfeed on discharge (yes, no or missing data), maternal cigarette smoking anytime during pregnancy (yes, no or missing data), maternal history of asthma \[[@C30]\], maternal atopy status (see supplemental material regarding maternal asthma and atopy case definitions) \[[@C9]\], gestational age (in weeks), birthweight and an indicator for urban/rural place of residence (see [online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials) regarding details on urban/rural indicator). Exposure to residential greenness during pregnancy was obtained using the satellite-derived normalised difference vegetation index (NDVI) and exposure was assigned at the postal code level \[[@C31]\] (see [online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials) regarding exposure assessment of NDVI). In addition, we abstracted three contextual socioeconomic status (SES) variables (*i.e.* median family income, proportion of visible minority and percentage of females aged 25--64 years who completed post-secondary education).

Statistical analysis {#s2e}
--------------------

We employed random-effects Cox proportional hazards models to evaluate the associations between exposure to air pollution during pregnancy and incidence of childhood asthma, in which random effects were represented by two levels of spatial clusters: census division (equivalent in size to a county) and census tract within census divisions \[[@C24], [@C32]\]. Follow-up time (*i.e.* child age in days) was measured from birth until incidence of childhood asthma, death, ineligibility for provincial health insurance or end of follow-up. We conducted analyses for the whole pregnancy, trimester-specific exposures, first year of life and childhood exposures. Models were conducted with and without mutual adjustment for average pregnancy exposure, first year of life exposure and cumulative exposure after birth. For instance, in the mutually adjusted models, effect estimates for the average pregnancy exposure were additionally adjusted for the first year of life exposure and the cumulative exposure after birth. Hazard ratios for trimester-specific exposures in mutually adjusted models accounted for average pregnancy exposure, first year of life exposure and cumulative exposure after birth. Additionally, we adjusted for pregnancy average exposure in postnatal exposure models. Proportional hazards assumptions were verified by adding the cross product of each variable with the natural logarithm of the time variable, but we did not find any significant violations of this assumption (p\>0.05). Results are expressed as the hazard ratio (HR) and 95% confidence interval corresponding to an increase across the interquartile range (IQR) of NO~2~ and PM~2.5~. Concentration response curves were evaluated using recently published methods \[[@C33]\].

We conducted stratified analyses to assess potential effect modification by selected individual (*i.e.* maternal history of asthma, maternal atopy status, maternal smoking during pregnancy, birthweight, gestational age and infant sex) and contextual (*i.e.* urban/rural status) characteristics. We evaluated the significance of effect modification on the multiplicative scale by including a cross product interaction term between each exposure of interest (*i.e.* PM~2.5~ and NO~2~) and each characteristic. Wald\'s method was used to assess the presence of interaction on the multiplicative scale. Effect modification was considered statistically significant if the interaction term p-value was \<0.05. In addition, we investigated the interaction between air pollution and maternal asthma as well as maternal atopy on the additive scale using the relative excess risk due to interaction (RERI), given that joint effects are also of interest. We categorised PM~2.5~ and NO~2~ in quartiles for this analysis. We used mothers without asthma (or mothers without an atopic disease) in the first exposure quartiles of either PM~2.5~ or NO~2~ as the reference category for the following groups (annotations in parentheses): presence of maternal asthma (or maternal atopy) and fourth quartile exposure of either PM~2.5~ or NO~2~ (HR~10~); absence of maternal asthma (or maternal atopy) and first quartile exposure of either PM~2.5~ or NO~2~ (HR~01~); presence of maternal asthma (or maternal atopy) and fourth quartile exposure of either PM~2.5~ or NO~2~ (HR~11~). We calculated the RERI as HR~11~ − HR~10~ − HR~01~ + 1. A RERI of 0 indicates no interaction and a statistically significant RERI \>0 indicates the presence of supra-additivity or synergistic interaction \[[@C34]\]. The RERI and its 95% confidence interval were calculated according to the δ-method \[[@C35]\].

We conducted a number of sensitivity analyses including stratifying analyses by the child\'s age at diagnosis, restricting our analysis according to subjects that did not move during pregnancy and conducting two-pollutant models. Statistical analyses were peformed in R (version 3.0.1; [www.r-project.org](www.r-project.org)), using the "coxme" package. Ethics approval for this study was granted by the research ethics boards of Health Canada, the Children\'s Hospital of Eastern Ontario and the Ottawa Health Science Network.

Results {#s3}
=======

Descriptive statistics {#s3a}
----------------------

761 172 singleton live births occurring between April 1, 2006 and March 31, 2012 were identified in the province of Ontario, Canada ([table 1](#TB1){ref-type="table"}). Among these, 110 981 children developed asthma before the age of 6 years with a mean age at asthma diagnosis of 2.1 years. Children with asthma had a smaller birthweight (3327.9±596.3 g *versus* 3397.1±540.5 g), a slightly shorter gestational age (38.6±2.1 weeks *versus* 38.9±1.7 weeks) and were more frequently born to mothers with a history of asthma (8.4% *versus* 5.6%). There was a male predominance among asthmatic children (60.5% *versus* 49.8%). Furthermore, 45 443 mothers were found to have a history of asthma. TABLE 1Demographic and socioeconomic characteristics of study participants**Total cohortAsthmatic childrenNonasthmatic childrenSubjects**761 172110 981650 191**Maternal age years**30.0±5.530.1±5.530.0±5.5**Gestational age weeks**38.9±1.838.6±2.138.9±1.7**Birthweight g**3387.0±549.63327.9±596.33397.9±540.6**Infant sex** Male390 665 (51.3)67 171 (60.5)323 484 (49.8) Female370 507 (48.7)43 810 (39.5)326 697 (50.2)**Parity** 0385 336 (50.6)55 777 (50.3)329 559 (50.7) 1259 543 (34.1)39 004 (35.1)220 539 (33.9) ≥2116 293 (15.3)16 200 (14.6)100 093 (15.4)**Intention to breastfeed** Yes606 236 (79.6)87 503 (78.8)518 733 (79.8) No64 787 (8.5)9607 (8.7)55 180 (8.5) Missing90 149 (11.8)13 871 (12.5)76 278 (11.7)**Maternal smoking status during pregnancy** Yes79 718 (10.5)11 398 (10.3)68 320 (10.5) No597 907 (78.6)86 761 (78.2)511 146 (78.6) Missing83 547 (11.0)12 822 (11.6)70 725 (10.9)**Maternal asthma** Yes45 443 (6.0)9299 (8.4)36 144 (5.6) No715 729 (94.0)101 682 (91.6)614 047 (94.4)**Median family income** Quintile 1149 838 (19.7)23 566 (21.2)126 272 (19.4) Quintile 2149 405 (19.6)21 798 (19.6)127 607 (19.6) Quintile 3150 339 (19.8)20 974 (18.9)129 365 (19.9) Quintile 4149 788 (19.7)21 826 (19.7)127 962 (19.7) Quintile 5149 872 (19.7)21 115 (19.0)128 757 (19.8) Missing11 930 (1.6)1702 (1.5)10 228 (1.6)**Percentage of females who completed post-secondary education (age ≥25 years)** Quintile 1124 580 (19.7)16 649 (18.0)107 931 (20.0) Quintile 2125 085 (19.8)18 278 (19.7)106 807 (19.8) Quintile 3124 050 (19.6)18 663 (20.1)105 387 (19.5) Quintile 4124 767 (19.7)18 932 (20.4)105 835 (19.6) Quintile 5124 508 (19.7)18 848 (20.3)105 660 (19.6) Missing8966 (1.4)1310 (1.4)7656 (1.4)**Percentage visible minority** Quintile 1149 652 (19.7)16 203 (14.6)133 449 (20.5) Quintile 2149 888 (19.7)18 687 (16.8)131 201 (20.2) Quintile 3149 768 (19.7)21 185 (19.1)128 583 (19.8) Quintile 4149 744 (19.7)24 620 (22.2)125 124 (19.2) Quintile 5149 777 (19.7)28 527 (25.7)121 250 (18.6) Missing12 343 (1.6)1759 (1.6)10 584 (1.6)Data are presented as n, mean±[sd]{.smallcaps} or n (%).

The IQR for PM~2.5~ was 3.7 μg·m^−3^ and the IQR for NO~2~ was 8.6 ppb over the period of the whole pregnancy ([table 2](#TB2){ref-type="table"}). PM~2.5~ was moderately correlated with NO~2~ during the entire pregnancy period (r=0.49) ([online supplementary table S1](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials)). Moderate correlations were observed between trimester-specific periods and exposures after birth to PM~2.5~ (r=0.54--0.74). In addition, moderate Pearson correlations were found between specific periods of exposure to NO~2~ (r=0.51--0.78). Average long-term air pollution exposure (*i.e.* combining pregnancy exposure and exposures after birth) in mothers with asthma was slightly lower (7.2 μg·m^−3^ for PM~2.5~ and 12.5 ppb for NO~2~) compared to mothers without asthma (7.4 μg·m^−3^ for PM~2.5~ and 13.3 ppb for NO~2~) (results not shown in tables). We observed negative correlations between long term PM~2.5~ (r=−0.44) and NO~2~ (r=−0.43) exposures with residential greenness exposure during pregnancy.

###### 

Hazard ratios (HR) and 95% confidence intervals for the associations between nitrogen dioxide (NO~2~) (per interquartile range (IQR)) and particulate matter with a 50% cut-off aerodynamic diameter ≤2.5 μm (PM~2.5~) (per IQR) over specific periods and childhood asthma risk

                                       **NO~2~**   **PM**~**2.5**~                                                                             
  ----------------------------------- ----------- ----------------- ------------------- ------------------- -------- ----- ------------------- -------------------
  **1st trimester**                     28 292           9.6         1.12 (1.10--1.15)   1.02 (1.00--1.05)   84 429   4.1   1.01 (1.00--1.03)   1.01 (1.00--1.03)
  **2nd trimester**                     27 874           9.7         1.19 (1.17--1.21)   1.06 (1.03--1.08)   84 398   3.9   1.09 (1.08--1.10)   1.07 (1.06--1.09)
  **3rd trimester**                     27 260           9.5         0.99 (0.97--1.01)   0.98 (0.96--1.00)   84 056   3.8   1.02 (1.00--1.04)   1.01 (0.99--1.03)
  **Entire pregnancy**                  27 213           8.6         1.09 (1.07--1.12)   1.02 (0.99--1.05)   83 470   3.7   1.02 (0.99--1.04)   1.01 (0.99--1.04)
  **First year of life**                27 213           8.9         1.08 (1.06--1.09)   1.03 (1.00--1.06)   83 470   3.6   0.99 (0.98--1.00)   0.99 (0.98--1.00)
  **Childhood cumulative exposure**     26 519           8.6         1.00 (0.98--1.02)   1.00 (0.97--1.03)   82 520   3.3   1.00 (1.00--1.01)   1.00 (1.00--1.01)

Data are presented as n or HR (95% CI). ^\#^: model adjusted for maternal age at delivery, infant sex, parity, breastfeeding status at the time of discharge, maternal smoking during pregnancy, maternal atopy, gestational age, birthweight, residential greenness exposure during pregnancy, dissemination area median family income, dissemination area proportion of population who are visible minority and dissemination area proportion of the adult female population aged 25--64 years old who completed post-secondary education; ^¶^: includes all variables in the adjusted model plus the average pregnancy exposure to the selected pollutant, the first year of life exposure to the selected pollutant and cumulative exposure after birth to the selected pollutant IQR.

Air pollution and childhood asthma associations {#s3b}
-----------------------------------------------

The associations between exposure to PM~2.5~ and NO~2~ on childhood asthma incidence over specific time periods of pregnancy are presented in [table 2](#TB2){ref-type="table"}. We found that additional adjustment for the pregnancy average exposure and the exposures after birth decreased effect estimates in most associations. In fact, we found statistically significant hazard ratios for exposures to NO~2~ (1.06, 95% CI 1.03--1.08) and PM~2.5~ (1.07, 95% CI 1.06--1.09) only for the second trimester when additionally adjusting for exposures to the selected pollutant during the whole pregnancy and exposures after birth. Supplementary analyses using concentration--response functions using natural cubic splines with three degrees of freedom \[[@C33]\] for NO~2~ and PM~2.5~ during the second trimester with adjustment for all the same covariates reported in [table 2](#TB2){ref-type="table"} (*i.e.* mutually adjusted model) confirmed linearity of associations with incident asthma throughout the distribution of air pollutant concentrations ([online supplementary figure S2](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials)). Exposure to residential greenness during pregnancy appeared to be independently associated with reduced risk of childhood asthma (HR 0.83, 95% CI 0.82--0.83) after adjustment for air pollution measures (result not shown).

Air pollution and childhood asthma effect modification {#s3c}
------------------------------------------------------

Stratified analyses, adjusted for a number of covariates including the mutual adjustment for pregnancy average and exposures after birth, are presented in [tables 3](#TB3){ref-type="table"} and [4](#TB4){ref-type="table"}. Analyses stratified according to gestational age showed that children born preterm were at highest risk (HR 1.11, 95% CI 1.08--1.14) of developing childhood asthma per 9.7 ppb increase in exposure to NO~2~ during the second trimester when compared to the risk for those born at term (HR 1.06, 95% CI 1.03--1.08) (p-value=0.04) ([table 3](#TB3){ref-type="table"}). Stratification by maternal place of residence showed that children born to mothers who were living in urban areas during their pregnancy had a heightened impact of exposure to NO~2~ during the first trimester on childhood asthma development (p-value for effect modification=0.04). In addition, we found statistically significant effect modification by infant sex, with males having higher risks of developing asthma, for exposures to PM~2.5~ in trimesters 1 and 2 (p-values for effect modification ≤0.04) ([table 4](#TB4){ref-type="table"}). In addition, stratified regressions revealed that low-birthweight infants, those born preterm and those born to mothers who smoked during pregnancy were at an increased risk for asthma when exposed to increased levels of PM~2.5~ compared to their counterparts (p-values for effect modification ≤0.04). Given that maternal smoking during pregnancy is negatively associated with gestational age and birthweight, we restricted our analysis of effect modification by gestational age and birthweight to those who did not smoke during pregnancy. Results for effect modification by gestational age and birthweight remained statistically significant (p-values for effect modification ≤0.04; results not shown).

###### 

Adjusted^\#^ hazard ratios (HR) and 95% confidence intervals for the associations between nitrogen dioxide (NO~2~) per interquartile range over specific periods and childhood asthma risk~,~ stratified by selected characteristics

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                           **1st trimester**   **2nd trimester**   **3rd trimester**      **Entire**\      **First year of**\   **Childhood cumulative**\
                                                                                                         **pregnancy**          **life**              **exposure**
  --------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------- ---------------------------
  **Maternal asthma**                                                                                                                          

   Yes                                     1.04 (0.98--1.10)   1.09 (1.03--1.15)   1.00 (0.95--1.05)   1.03 (0.96--1.10)   1.04 (1.00--1.08)        1.00 (0.96--1.04)

   No                                      1.02 (0.99--1.04)   1.06 (1.03--1.08)   0.98 (0.96--1.00)   1.02 (0.99--1.05)   1.03 (0.99--1.06)        1.00 (0.97--1.03)

   p-value for effect modification               0.65                0.38                0.42                0.49                 0.64                    0.75

  **Maternal atopy**                                                                                                                           

   Yes                                     1.07 (1.00--1.14)   1.12 (1.05--1.19)   1.01 (0.96--1.07)   1.06 (0.99--1.13)   1.08 (1.00--1.15)        1.01 (0.96--1.05)

   No                                      1.02 (1.00--1.05)   1.06 (1.03--1.08)   0.98 (0.96--1.00)   1.02 (0.99--1.05)   1.03 (1.00--1.06)        1.00 (0.97--1.03)

   p-value for effect modification               0.21                0.16                0.78                0.34                 0.32                    0.92

  **Maternal smoking during pregnancy**                                                                                                        

   Yes                                     1.08 (1.03--1.13)   1.11 (1.05--1.16)   1.05 (1.00--1.10)   1.07 (1.01--1.13)   1.05 (1.00--1.10)        1.00 (0.93--1.07)

   No                                      1.02 (1.00--1.05)   1.06 (1.03--1.08)   1.00 (0.98--1.02)   1.02 (0.99--1.05)   1.03 (1.00--1.06)        1.00 (0.97--1.03)

   p-value for effect modification               0.11                0.19                0.07                0.17                 0.44                    0.96

  **Infant sex**                                                                                                                               

   Male                                    1.03 (1.00--1.06)   1.06 (1.04--1.08)   1.00 (0.98--1.03)   1.02 (0.99--1.04)   1.03 (1.00--1.06)        1.00 (0.97--1.04)

   Female                                  1.02 (1.00--1.05)   1.06 (1.03--1.08)   1.00 (0.97--1.03)   1.02 (0.99--1.05)   1.03 (1.00--1.06)        1.00 (0.97--1.03)

   p-value for effect modification               0.55                0.88                0.74                0.92                 0.57                    0.84

  **Maternal place of residence**                                                                                                              

   Urban                                   1.04 (1.01--1.07)   1.06 (1.03--1.08)   1.00 (0.98--1.03)   1.02 (0.99--1.05)   1.04 (1.02--1.06)        1.00 (0.97--1.03)

   Rural                                   0.75 (0.55--1.01)   0.98 (0.71--1.34)   1.00 (0.67--1.45)   0.99 (0.58--1.55)   1.00 (0.60--1.59)        0.99 (0.61--1.65)

   p-value for effect modification               0.04                0.51                0.97                0.88                 0.75                    0.88

  **Gestational age**                                                                                                                          

   \<37 weeks                              1.02 (1.00--1.05)   1.11 (1.08--1.14)   1.02 (0.98--1.06)   1.05 (1.00--1.09)   1.04 (0.99--1.09)        1.00 (0.95--1.05)

   ≥37 weeks                               1.03 (1.00--1.06)   1.06 (1.03--1.08)   0.98 (0.96--1.01)   1.02 (0.99--1.05)   1.03 (1.00--1.06)        1.00 (0.98--1.02)

   p-value for effect modification               0.44                0.04                0.33                0.43                 0.86                    0.98

  **Birthweight**                                                                                                                              

   \<2500 g                                1.01 (0.99--1.04)   1.05 (0.99--1.11)   1.03 (0.96--1.10)   1.04 (0.97--1.11)   1.06 (0.99--1.13)        1.00 (0.92--1.08)

   ≥2500 g                                 1.02 (1.00--1.05)   1.06 (1.02--1.08)   1.00 (0.98--1.02)   1.02 (0.99--1.05)   1.03 (1.00--1.06)        1.00 (0.97--1.03)

   p-value for effect modification               0.77                0.72                0.33                0.63                 0.34                    0.98
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as HR (95% CI), unless otherwise stated. ^\#^: models adjusted for maternal age at delivery, infant sex (except for stratified analyses by infant sex), parity, breastfeeding status at the time of discharge, maternal smoking during pregnancy (except for stratified analyses by maternal smoking), maternal atopy (except for stratified analyses by maternal asthma and by maternal atopy), gestational age (except for stratified analyses by gestational age), birthweight (except for stratified analyses by birthweight), residential greenness exposure during pregnancy, dissemination area median family income, dissemination area proportion of population who are visible minority, dissemination area proportion of the adult female population aged 25--64 years who completed post-secondary education, the average pregnancy exposure to the selected pollutant, the first year of life exposure to the selected pollutant and cumulative exposure after birth to the selected pollutant.

###### 

Adjusted^\#^ hazard ratios (HR) and 95% confidence intervals for the associations between particulate matter with a 50% cut-off aerodynamic diameter ≤2.5 μm (PM~2.5~) per interquartile range over specific periods and childhood asthma risk~,~ stratified by selected characteristics

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                           **1st trimester**   **2nd trimester**   **3rd trimester**      **Entire**\      **First year of**\   **Childhood cumulative**\
                                                                                                         **pregnancy**          **life**              **exposure**
  --------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------- ---------------------------
  **Maternal asthma**                                                                                                                          

   Yes                                     0.99 (0.94--1.02)   1.08 (1.05--1.11)   1.02 (0.99--1.05)   1.02 (0.98--1.07)   1.00 (0.95--1.06)        1.00 (0.93--1.08)

   No                                      1.01 (1.00--1.03)   1.07 (1.06--1.09)   1.01 (0.99--1.03)   1.01 (0.98--1.04)   0.99 (0.98--1.00)        1.00 (0.99--1.01)

   p-value for effect modification               0.26                0.92                0.67                0.81                 0.88                    0.94

  **Maternal atopy**                                                                                                                           

   Yes                                     1.03 (0.99--1.07)   1.09 (1.05--1.13)   1.02 (0.98--1.07)   1.03 (0.97--1.08)   1.02 (0.98--1.05)        1.00 (0.94--1.07)

   No                                      1.01 (0.99--1.03)   1.07 (1.06--1.09)   1.01 (0.99--1.03)   1.01 (0.99--1.04)   0.98 (0.97--1.01)        1.00 (0.98--1.01)

   p-value for effect modification               0.35                0.34                0.61                0.55                 0.48                    0.72

  **Maternal smoking during pregnancy**                                                                                                        

   Yes                                     1.07 (1.03--1.12)   1.12 (1.09--1.14)   1.05 (1.02--1.08)   1.07 (1.04--1.11)   1.00 (0.98--1.03)        0.99 (0.96--1.01)

   No                                      1.01 (1.00--1.03)   1.07 (1.06--1.09)   1.01 (0.99--1.03)   1.01 (0.98--1.04)   0.99 (0.98--1.00)        0.99 (0.98--1.00)

   p-value for effect modification               0.04                0.04                0.08                0.04                 0.91                    0.91

  **Infant sex**                                                                                                                               

   Male                                    1.04 (1.02--1.06)   1.09 (1.07--1.11)   1.01 (0.99--1.03)   1.03 (1.01--1.06)   1.00 (0.98--1.00)        1.00 (0.99--1.01)

   Female                                  1.00 (0.97--1.02)   1.05 (1.01--1.09)   1.00 (0.98--1.03)   1.01 (0.99--1.04)   1.00 (0.98--1.01)        1.00 (1.00--1.01)

   p-value for effect modification               0.04                0.04                0.35                0.12                 0.78                    0.96

  **Maternal place of residence**                                                                                                              

   Urban                                   1.01 (1.00--1.03)   1.08 (1.06--1.10)   1.01 (1.00--1.04)   1.01 (0.99--1.04)   1.00 (0.98--1.02)        1.00 (0.99--1.01)

   Rural                                   1.02 (0.98--1.07)   1.06 (1.00--1.11)   1.00 (0.95--1.06)   1.01 (0.98--1.04)   1.00 (0.95--1.07)        1.00 (0.95--1.06)

   p-value for effect modification               0.42                0.36                0.60                0.86                 0.67                    0.76

  **Gestational age**                                                                                                                          

   \<37 weeks                              1.06 (1.03--1.10)   1.13 (1.09--1.17)   1.03 (0.99--1.07)   1.04 (1.00--1.09)   1.00 (0.95--1.05)        1.00 (0.95--1.06)

   ≥37 weeks                               1.01 (1.00--1.03)   1.07 (1.06--1.09)   1.01 (0.99--1.03)   1.01 (0.99--1.04)   0.99 (0.98--1.00)        1.00 (1.00--1.01)

   p-value for effect modification               0.04                0.03                0.28                0.47                 0.68                    0.85

  **Birthweight**                                                                                                                              

   \<2500 g                                1.05 (1.02--1.08)   1.12 (1.08--1.16)   1.08 (1.03--1.13)   1.08 (1.04--1.12)   1.00 (0.95--1.06)        1.01 (0.95--1.07)

   ≥2500 g                                 1.00 (0.98--1.02)   1.07 (1.06--1.09)   1.01 (0.99--1.03)   1.01 (0.99--1.04)   0.99 (0.98--1.00)        1.00 (1.00--1.01)

   p-value for effect modification               0.04                0.03                0.04                0.04                 0.82                    0.73
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as HR (95% CI), unless otherwise stated. ^\#^: models adjusted for maternal age at delivery, infant sex (except for stratified analyses by infant sex), parity, breastfeeding status at the time of discharge, maternal smoking during pregnancy (except for stratified analyses by maternal smoking), maternal atopy (except for stratified analyses by maternal asthma and by maternal atopy), gestational age (except for stratified analyses by gestational age), birthweight (except for stratified analyses by birthweight), residential greenness exposure during pregnancy, dissemination area median family income, dissemination area proportion of population who are visible minority, dissemination area proportion of the adult female population aged 25--64 years old who completed post-secondary education, the average pregnancy exposure to the selected pollutant, the first year of life exposure to the selected pollutant and cumulative exposure after birth to the selected pollutant.

The risk of childhood asthma diagnosed before 6 years of age was significantly increased when evaluating effect modification on the additive scale for the combined effect of maternal asthma and exposure to NO~2~ ([table 5](#TB5){ref-type="table"}). The highest effect was observed among children whose exposure to NO~2~ during the second trimester was in the highest category of exposure (*i.e.* 4th quartile) and whose mothers had asthma (HR 1.87, 95% CI 1.69--2.07). RERI estimates for joint effects of high NO~2~ exposure and maternal asthma on childhood asthma incidence exceeded 0 for second trimester exposure and RERI was statistically significant, which suggests supra-additivity (*i.e.* synergistic effects) for interaction on the additive scale. No evidence of effect modification on the additive scale was found for the other associations investigated ([tables 5](#TB5){ref-type="table"} and [6](#TB6){ref-type="table"}) and for effect modification by maternal atopy on the additive scale (results not shown).

###### 

Adjusted^\#^ hazard ratios (HR) and 95% confidence intervals for the joint effects of maternal asthma and quartiles of nitrogen dioxide (NO~2~) exposure over specific periods of pregnancy on childhood asthma risk

  **Maternal asthma**       **NO~2~ quartiles**   **Subjects**   **Obstetric cases**    **HR (95% CI)**    **RERI (95% CI)**
  ------------------------ --------------------- -------------- --------------------- ------------------- --------------------
  **1st trimester**                                                                                        0.08 (−0.02--0.18)
   No                               Q1               56 939             7142                 Ref.         
   No                               Q2               55 953             7542           1.00 (0.96--1.05)  
   No                               Q3               54 914             8499           1.05 (0.99--1.11)  
   No                               Q4               55 204             9613           1.10 (1.02--1.18)  
   Yes                              Q1                3951               767           1.59 (1.48--1.71)  
   Yes                              Q2                3206               642           1.53 (1.41--1.66)  
   Yes                              Q3                3012               720           1.68 (1.53--1.84)  
   Yes                              Q4                2821               765           1.77 (1.67--1.97)  
  **2nd trimester**                                                                                        0.18 (0.08--0.28)
   No                               Q1               56 836             7156                 Ref.         
   No                               Q2               55 541             7593           1.02 (0.98--1.06)  
   No                               Q3               54 512             8290           1.09 (1.04--1.15)  
   No                               Q4               54 660             9504           1.16 (1.08--1.26)  
   Yes                              Q1                3930               744           1.53 (1.42--1.65)  
   Yes                              Q2                3214               665           1.59 (1.48--1.73)  
   Yes                              Q3                2988               703           1.75 (1.60--1.91)  
   Yes                              Q4                2811               755           1.87 (1.69--2.07)  
  **3rd trimester**                                                                                        0.07 (−0.03--0.16)
   No                               Q1               56 139             7147                 Ref.         
   No                               Q2               55 097             7669           1.00 (0.96--1.04)  
   No                               Q3               54 221             8207           1.02 (0.96--1.07)  
   No                               Q4               54 247             9171           1.06 (0.98--1.15)  
   Yes                              Q1                3851               745           1.54 (1.43--1.66)  
   Yes                              Q2                3240               671           1.56 (1.44--1.70)  
   Yes                              Q3                2953               696           1.61 (1.47--1.77)  
   Yes                              Q4                2794               748           1.66 (1.49--1.81)  
  **Entire pregnancy**                                                                                     0.06 (−0.04--0.15)
   No                               Q1               54 748             6928                 Ref.         
   No                               Q2               52 430             6908           0.95 (0.91--1.00)  
   No                               Q3               52 598             7964           1.03 (0.97--1.09)  
   No                               Q4               52 374             9307           1.10 (1.02--1.19)  
   Yes                              Q1                3811               738           1.55 (1.44--1.68)  
   Yes                              Q2                3075               587           1.40 (1.28--1.53)  
   Yes                              Q3                2794               689           1.66 (1.51--1.82)  
   Yes                              Q4                2645               730           1.72 (1.54--1.91)  
  **First year of life**                                                                                   0.08 (−0.01--0.18)
   No                               Q1               53 730             6724                 Ref.         
   No                               Q2               51 233             6689           1.00 (0.97--1.03)  
   No                               Q3               51 107             7625           1.06 (1.01--1.12)  
   No                               Q4               50 074             9102           1.12 (1.04--1.21)  
   Yes                              Q1                3731               727           1.55 (1.43--1.67)  
   Yes                              Q2                2977               562           1.60 (1.48--1.72)  
   Yes                              Q3                2523               668           1.68 (1.53--1.83)  
   Yes                              Q4                2427               717           1.75 (1.59--1.92)  

Data are presented as n, unless otherwise stated. Q: quartile; RERI: relative excess risk of childhood asthma due to interaction between maternal asthma and NO~2~. ^\#^: models adjusted for maternal age at delivery, infant sex, parity, breastfeeding status at the time of discharge, maternal smoking during pregnancy, gestational age, birthweight, residential greenness exposure during pregnancy, dissemination area median family income, dissemination area proportion of population who are visible minority, dissemination area proportion of the adult female population aged 25--64 years who completed post-secondary education, the average pregnancy exposure to the selected pollutant, the first year of life exposure to the selected pollutant and cumulative exposure after birth to the selected pollutant.

###### 

Adjusted^\#^ hazard ratios (HR) and 95% confidence intervals for the joint effects of maternal asthma and quartiles of particulate matter with a 50% cut-off aerodynamic diameter ≤2.5 μm (PM~2.5~) exposure over specific periods of pregnancy on childhood asthma risk

  **Maternal asthma**       **PM**~**2.5**~ **quartiles**   **Subjects n**   **Obstetric cases**    **HR (95% CI)**     **RERI (95% CI)**
  ------------------------ ------------------------------- ---------------- --------------------- ------------------- ---------------------
  **1st trimester**                                                                                                    −0.06 (−0.16--0.03)
   No                                    Q1                    145 559             17 807                Ref.         
   No                                    Q2                    143 670             19 323          1.00 (0.97--1.02)  
   No                                    Q3                    139 399             20 506          1.03 (1.00--1.07)  
   No                                    Q4                    139 781             21 964          1.06 (1.00--1.12)  
   Yes                                   Q1                     10 162              1854           1.56 (1.49--1.64)  
   Yes                                   Q2                      9218               1738           1.46 (1.39--1.54)  
   Yes                                   Q3                      8531               1881           1.63 (1.54--1.73)  
   Yes                                   Q4                      8140               1811           1.56 (1.45--1.67)  
  **2nd trimester**                                                                                                    −0.04 (−0.06--0.13)
   No                                    Q1                    146 044             17 705                Ref.         
   No                                    Q2                    144 005             19 595          1.02 (0.99--1.05)  
   No                                    Q3                    140 194             20 412          1.03 (0.99--1.07)  
   No                                    Q4                    138 903             21 928          1.07 (1.02--1.13)  
   Yes                                   Q1                     10 259              1779           1.49 (1.42--1.57)  
   Yes                                   Q2                      9187               1820           1.55 (1.47--1.63)  
   Yes                                   Q3                      8489               1849           1.62 (1.53--1.72)  
   Yes                                   Q4                      8161               1837           1.60 (1.50--1.72)  
  **3rd trimester**                                                                                                    −0.03 (−0.12--0.06)
   No                                    Q1                    146 293             17 831                Ref.         
   No                                    Q2                    145 118             19 782          1.00 (0.97--1.03)  
   No                                    Q3                    139 473             19 962          0.98 (0.95--1.02)  
   No                                    Q4                    138 104             21 901          1.03 (0.98--1.09)  
   Yes                                   Q1                     10 268              1820           1.52 (1.45--1.60)  
   Yes                                   Q2                      9262               1821           1.51 (1.43--1.59)  
   Yes                                   Q3                      8356               1790           1.54 (1.47--1.64)  
   Yes                                   Q4                      8218               1840           1.52 (1.42--1.63)  
  **Entire pregnancy**                                                                                                 −0.04 (−0.14--0.05)
   No                                    Q1                    142 313             16 929                Ref.         
   No                                    Q2                    142 474             19 688          1.03 (1.00--1.06)  
   No                                    Q3                    141 971             19 741          0.95 (0.91--1.00)  
   No                                    Q4                    135 596             22 224          1.07 (1.00--1.13)  
   Yes                                   Q1                     10 041              1768           1.55 (1.47--1.62)  
   Yes                                   Q2                      9096               1788           1.54 (1.46--1.62)  
   Yes                                   Q3                      8653               1808           1.50 (1.41--1.59)  
   Yes                                   Q4                      7850               1831           1.58 (1.47--1.70)  
  **First year of life**                                                                                               0.01 (−0.08--0.10)
   No                                    Q1                    141 974             16 918                Ref.         
   No                                    Q2                    142 101             19 682          0.99 (0.96--1.02)  
   No                                    Q3                    141 788             19 738          1.00 (0.95--1.05)  
   No                                    Q4                    134 323             22 221          1.02 (0.98--1.07)  
   Yes                                   Q1                      9874               1766           1.55 (1.46--1.61)  
   Yes                                   Q2                      8921               1784           1.53 (1.41--1.60)  
   Yes                                   Q3                      8365               1807           1.57 (1.45--1.64)  
   Yes                                   Q4                      7538               1830           1.59 (1.46--1.69)  

Data are presented as n, unless otherwise stated. Q: quartile; RERI: relative excess risk of childhood asthma due to interaction between maternal asthma and PM~2.5~. ^\#^: models adjusted for maternal age at delivery, infant sex, parity, breastfeeding status at the time of discharge, maternal smoking during pregnancy, gestational age, birthweight, residential greenness exposure during pregnancy, dissemination area median family income, dissemination area proportion of population who are visible minority, dissemination area proportion of the adult female population aged 25--64 years who completed post-secondary education, the average pregnancy exposure to the selected pollutant, the first year of life exposure to the selected pollutant and cumulative exposure after birth to the selected pollutant.

Sensitivity analyses {#s3d}
--------------------

We conducted a number of sensitivity analyses. When stratifying the analysis by the child\'s age at diagnosis (\<1 year *versus* 1--5 years of age), we found no differences in effect estimates (data not shown). In addition, we found \<3% differences in risk estimates when comparing those that did not move during pregnancy or during childhood years compared to all subjects (results not shown). In two-pollutant models, we found that effect estimates for both pollutants decreased slightly when adjusting for the other pollutant ([online supplementary table S2](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials)). In addition, we found that effect estimates for single-pollutant models restricted to those where both exposure estimates could be assigned were similar to the overall models ([online supplementary table S2](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials)). The same pattern was observed when investigating two-pollutant models when evaluating effect modification (*i.e.* \<3% difference in risk estimates; results not shown). Results of the evaluation of the joint effects between NO~2~ during the second trimester and maternal asthma were robust to adjustment for cumulative exposures after birth (results not shown). In addition, we investigated associations restricted to term births weighing ≥2500 grams (*i.e.* without adjustment for birthweight and gestational age, since these factors may be on the causal pathway between prenatal exposure to air pollution and childhood asthma), but risk estimates were materially unchanged (results not shown). We investigated whether parity was an effect modifier in the relationship between air pollution variables and asthma development, but findings did not reveal presence of effect modification (p-value for effect modification ≥0.11; results not shown).

Discussion {#s4}
==========

In this population-based study in the largest province of Canada, we examined associations between prenatal and early postnatal life exposure to air pollution and early childhood asthma incidence. We found that second-trimester exposures to NO~2~ and PM~2.5~ were associated with increased risks of developing asthma in children up to 6 years of age. In addition, we found evidence suggestive that children of mothers who had asthma and who were in the upper quartile of exposure to NO~2~ during the second trimester were approximately two times more at risk of developing asthma before 6 years of age. Increased effects of exposure to air pollution on childhood asthma incidence were found for those born preterm or of low birthweight, males, those born to mothers who smoked during pregnancy and those born to mothers living in urban areas during pregnancy.

Many studies have investigated the association between childhood exposure to air pollution and asthma onset in children \[[@C3], [@C4]\], but few studies have investigated the effect of exposure to air pollution during specific periods of pregnancy on the risk of development of childhood asthma \[[@C9], [@C13], [@C14]\]. In a study conducted in China among 2598 children, exposure to increased levels of NO~2~ during the second trimester was associated with the development of asthma (odds ratio 1.72, 95% CI 1.02--2.97) \[[@C13]\]. A study conducted in Boston (MA, USA) evaluated the effect of weekly exposures to PM~2.5~ during pregnancy on the development of asthma among 736 full-term children \[[@C9], [@C14]\]. They found that PM~2.5~ exposure during the second trimester was associated with asthma development by the age of 6 years, but only among males. Additionally, M[orales]{.smallcaps} *et al*. \[[@C5]\] showed that second-trimester NO~2~ exposure was associated with decreased lung function at 4.5 years of age. Therefore, findings of our study for an effect of exposure to NO~2~ and PM~2.5~ during the second trimester of pregnancy on childhood asthma incidence are somewhat consistent with prior literature. Exposure to air pollution *in utero* may potentially have harmful effects on critical periods of development of the immune and respiratory systems \[[@C36]\]. In particular, lung development in the second trimester of pregnancy may be affected through an increase in inflammation and airway hyperresponsiveness, which may enhance susceptibility to asthma \[[@C9], [@C37]--[@C39]\].

We found that exposure to air pollution during the first year of life with additional adjustment for pregnancy exposure was not associated with childhood asthma development. Although few studies have attempted to disentangle these relationships, M[orales]{.smallcaps} *et al*. \[[@C5]\] found that exposure to outdoor air pollutants in early postnatal life was not associated with lung function deficits at preschool age. However, a recent study showed that exposure to traffic-related air pollution in infancy is negatively associated with forced expiratory volume in 1 s at 16 years of age \[[@C8]\]. This could imply that effects of exposure during the first year of life may not be long enough to have an impact on childhood asthma development. Therefore, further studies are required to disentangle the impact of prenatal and postnatal exposure to air pollution on development of respiratory outcomes in later childhood and adolescence.

We found evidence that impacts on childhood asthma diagnosed before 6 years of age increased in a synergistic manner when evaluating the joint effect of maternal asthma and high levels of exposure to NO~2~ during the second trimester of pregnancy. To our knowledge, no previous study has investigated this important issue. Prior literature has shown that inhalation of gaseous pollutants can induce pro-inflammatory processes in the lungs of pregnant females \[[@C40]\]. Inflammation is a characteristic feature of the pathophysiology of asthma \[[@C17]\]. It is therefore biologically plausible that inflammation from exposure to air pollution during pregnancy combined with inflammation due to maternal presence of asthma induces a synergistic effect on childhood asthma development. This could occur through an alteration of immune responses \[[@C41]\]. Additionally, our findings could reflect the fact that traffic pollution may potentiate airway inflammation in already sensitised children through an epigenetic pathway (*i.e.* those with a genetic susceptibility to develop asthma) \[[@C42]\]. These findings require further investigation.

Our results confirm the previously reported finding that children weighing \<2500 g at birth were at higher risk of developing asthma during childhood following exposure to air pollution during the gestational period \[[@C11]\]. In addition, we found stronger impacts from exposure to air pollution on development of childhood asthma among children born preterm compared to those born full-term, and those born to mothers living in urban areas during pregnancy compared to rural areas. This finding is relevant as it shows greater susceptibility among those living in urban areas \[[@C43]\]. This may relate to the "hygiene hypothesis", where living in urban areas characterised by wealthy lifestyles and wealthy housing characteristics may increase risk of developing asthma. In addition, a protective effect of microbial exposures from rural environments has been reported \[[@C44]\]. We found higher effects for those born to mothers who smoked during pregnancy. Our findings for higher effects of prenatal exposure to PM~2.5~ on childhood asthma incidence among males is consistent with one previous study \[[@C9], [@C14]\].

Some limitations of our study need to be acknowledged. First, we could assign NO~2~ exposures only to participants that were within 25 km of a ground monitor in order to apply the temporal scaling described in the [online supplementary material](http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01884-2017.figures-only#fig-data-supplementary-materials). This decreased the sample sizes for analysis when investigating NO~2~ exposures, but probably reduced the likelihood of misclassification bias in exposure \[[@C45]\]. Second, while we included a number of important confounding factors, we cannot rule out potential residual confounding. For example, we did not have individual-level information on ethnicity, income, education or maternal stress levels. However, adjustment for area-level SES factors may have partially accounted for confounding for some of these missing variables. We did not have information on maternal obesity in pregnancy or maternal gestational weight gain, both of which are important risk factors for childhood asthma development \[[@C46]\]. However, a sensitivity analysis among a subset of our cohort (*i.e.* ∼20% of our cohort) with information on maternal pre-pregnancy body mass index indicated that adjustment for this factor did not materially change the main effect estimates (results not shown). Another limitation is related to the fact that we identified cases of asthma based on health administrative databases, which may lead to some level of misclassification bias. For example, we did not have information on asthma phenotypes and asthma severity. We also did not have information on medications used to treat or control asthma during pregnancy. However, a recent Canadian study that used a similar physician-diagnosed asthma case ascertainment as our study showed that traffic-related air pollution was associated with asthma status that was maintained over a 10-year follow-up. Therefore, this provides support that we likely captured "true" asthma cases. In addition, children aged \<5 years with symptoms of wheeze due to viral infections may be misdiagnosed as having asthma \[[@C23], [@C47]\]. However, we used a validated case definition in identifying asthma among both children and adults \[[@C30]\]. Finally, we could have underestimated asthma diagnosis in mothers since the data we used to identify maternal asthma went as far back as 1991, and therefore we would not identify those diagnosed with asthma during childhood. In addition, if these mothers had asthma during their early childhood and were well controlled afterwards without any documented healthcare use attributed to asthma, we would have missed them. Thus, we assume that most of the mothers with asthma captured through the health administrative database would be "prevalent" cases and/or may be those with relatively less well-controlled (or severe) asthma that would continue with encounters in the health care system during their adulthood \[[@C30]\].

Notable strengths of this study include the large sample size, availability of spatiotemporal air pollution exposure estimates available across a large geographical area and the attempt to capture residential mobility during pregnancy. The population-based approach is likely to have reduced risks of selection bias.

In this large population-based study, we found that exposure to ambient air pollution in pregnancy may increase the risk of asthma in young children. We observed enhanced effects of air pollution on the onset of childhood asthma diagnosed before 6 years of age among those born to mothers with a history of asthma, those born to mothers who smoked during pregnancy, in males and according to gestational age, birthweight and maternal place of residence. These findings highlight the need for further research to confirm relationships identified here and also the importance of developing public health and prenatal care strategies aimed at raising awareness and minimising exposure to ambient air pollution during pregnancy.
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